(CNN) -- The Food and Drug Administration announced Thursday it is conducting a safety review of the asthma drug Xolair after data from an ongoing study suggested an increased number of heart attacks and strokes among patients who use it.
Monday, July 20, 2009
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment